Pharsight

Drugs that contain Ospemifene

1. Osphena patents expiration

OSPHENA Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9566252 DUCHESNAY Method for the alleviation of dyspareunia in women
Nov, 2022

(1 year, 3 months ago)

US9241915 DUCHESNAY Method for enhancing the bioavailability of ospemifene
Feb, 2024

(11 days ago)

US8470890 DUCHESNAY Method for enhancing the bioavailability of ospemifene
Feb, 2024

(11 days ago)

US8772353 DUCHESNAY Method for enhancing the bioavalability of ospemifene
Feb, 2024

(11 days ago)

US9855224 DUCHESNAY Method for enhancing the bioavailability of ospemifene
Feb, 2024

(11 days ago)

US6245819 DUCHESNAY Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause
Jul, 2025

(1 year, 4 months from now)

US8236861 DUCHESNAY Method for enhancing the bioavailablity of ospemifene
Aug, 2026

(2 years from now)

US8642079 DUCHESNAY Solid formulations of ospemifene
Jul, 2028

(4 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Indication (I) Jan 25, 2022

Market Authorisation Date: 26 February, 2013

Treatment: Treatment of dyspareunia associated with menopause; Treatment of vaginal symptoms of urogenital atrophy by orally administering ospemifene with food to enhance bioavailability of ospemifene; Treatment...

Dosage: TABLET;ORAL

How can I launch a generic of OSPHENA before it's drug patent expiration?
More Information on Dosage

OSPHENA family patents

Family Patents